A detailed history of Calamos Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Calamos Advisors LLC holds 561,866 shares of JNJ stock, worth $81.6 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
561,866
Previous 619,649 9.33%
Holding current value
$81.6 Million
Previous $90.6 Million 0.54%
% of portfolio
0.57%
Previous 0.58%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$145.48 - $167.38 $8.41 Million - $9.67 Million
-57,783 Reduced 9.33%
561,866 $91.1 Million
Q2 2024

Jul 25, 2024

SELL
$144.38 - $157.78 $1.94 Million - $2.12 Million
-13,429 Reduced 2.12%
619,649 $90.6 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $1.49 Million - $1.56 Million
-9,610 Reduced 1.5%
633,078 $100 Million
Q4 2023

Jan 31, 2024

SELL
$145.6 - $158.88 $559,540 - $610,575
-3,843 Reduced 0.59%
642,688 $101 Million
Q3 2023

Oct 25, 2023

SELL
$155.75 - $174.48 $7.85 Million - $8.8 Million
-50,433 Reduced 7.24%
646,531 $101 Million
Q2 2023

Jul 28, 2023

BUY
$154.35 - $166.11 $102,951 - $110,795
667 Added 0.1%
696,964 $115 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $8.27 Million - $9.87 Million
-54,747 Reduced 7.29%
696,297 $108 Million
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $13.9 Million - $15.6 Million
-86,758 Reduced 10.36%
751,044 $0
Q3 2022

Oct 24, 2022

BUY
$161.33 - $179.52 $68,565 - $76,296
425 Added 0.05%
837,802 $137 Million
Q2 2022

Aug 01, 2022

BUY
$168.19 - $186.01 $8.56 Million - $9.47 Million
50,899 Added 6.47%
837,377 $149 Million
Q1 2022

May 03, 2022

BUY
$158.14 - $179.59 $18.4 Million - $20.9 Million
116,269 Added 17.35%
786,478 $139 Million
Q4 2021

Feb 01, 2022

SELL
$155.93 - $173.01 $9.49 Million - $10.5 Million
-60,871 Reduced 8.33%
670,209 $115 Million
Q3 2021

Oct 26, 2021

BUY
$161.5 - $179.47 $7.9 Million - $8.78 Million
48,943 Added 7.17%
731,080 $118 Million
Q2 2021

Jul 22, 2021

BUY
$159.48 - $171.07 $18.3 Million - $19.6 Million
114,852 Added 20.25%
682,137 $112 Million
Q1 2021

Apr 12, 2021

BUY
$153.07 - $170.48 $1.84 Million - $2.05 Million
12,031 Added 2.17%
567,285 $93.2 Million
Q4 2020

Jan 27, 2021

SELL
$137.11 - $157.38 $2.3 Million - $2.64 Million
-16,747 Reduced 2.93%
555,254 $87.4 Million
Q3 2020

Oct 26, 2020

SELL
$140.38 - $153.83 $4.86 Million - $5.33 Million
-34,641 Reduced 5.71%
572,001 $85.2 Million
Q2 2020

Jul 27, 2020

SELL
$128.81 - $155.51 $3.56 Million - $4.3 Million
-27,632 Reduced 4.36%
606,642 $85.3 Million
Q1 2020

Apr 28, 2020

SELL
$111.14 - $153.99 $69.4 Million - $96.2 Million
-624,480 Reduced 49.61%
634,274 $83.2 Million
Q4 2019

Jan 15, 2020

BUY
$127.5 - $146.44 $6.13 Million - $7.04 Million
48,041 Added 3.97%
1,258,754 $184 Million
Q3 2019

Oct 21, 2019

SELL
$126.95 - $142.14 $14.7 Million - $16.4 Million
-115,574 Reduced 8.71%
1,210,713 $157 Million
Q2 2019

Aug 07, 2019

SELL
$131.15 - $144.24 $18.3 Million - $20.1 Million
-139,369 Reduced 9.51%
1,326,287 $185 Million
Q1 2019

Apr 12, 2019

SELL
$125.72 - $139.79 $15.7 Million - $17.5 Million
-125,236 Reduced 7.87%
1,465,656 $205 Million
Q4 2018

Jan 24, 2019

SELL
$122.84 - $147.84 $15.3 Million - $18.4 Million
-124,315 Reduced 7.25%
1,590,892 $205 Million
Q3 2018

Oct 22, 2018

BUY
$121.58 - $142.88 $12.2 Million - $14.3 Million
99,970 Added 6.19%
1,715,207 $237 Million
Q2 2018

Jul 17, 2018

BUY
$119.4 - $131.76 $7.73 Million - $8.53 Million
64,712 Added 4.17%
1,615,237 $196 Million
Q1 2018

Apr 13, 2018

BUY
$125.1 - $148.14 $14.4 Million - $17 Million
114,913 Added 8.0%
1,550,525 $199 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $1.5 Million - $1.65 Million
-11,460 Reduced 0.79%
1,435,612 $201 Million
Q3 2017

Oct 25, 2017

BUY
$129.47 - $135.38 $34.4 Million - $36 Million
266,023 Added 22.52%
1,447,072 $188 Million
Q2 2017

Aug 09, 2017

BUY
N/A
1,181,049
1,181,049 $156 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.